Stay up to date with notifications from The Independent

Notifications can be managed in browser preferences.

View from City Road: A merger might make sense for Wellcome

Monday 18 July 1994 18:02 EDT
Comments

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

The obvious question about Wellcome's flat denial yesterday that the company had held talks about merging with a third party is - if not, why not? The past 18 months have seen the drug sector in turmoil as individual companies have struggled to come to terms with a radically different market place. Everyone has seemed to be talking to everyone about everything. It seems odd, to say the least, that Wellcome has not explored a solution that might have much to commend it.

Wellcome is a tempting target in many ways. It has a speciality - anti- virals - that would complement the price lists of many other pharmaceutical companies. It is also vulnerable in that it is over-dependent on one product, Zovirax. In addition, the trust that owns 40 per cent has made it clear it would like to reduce its stake further.

Clearly the trust is not about to assist in a hostile bid. So any deal would depend on convincing Wellcome's board of the logic behind a merger. So far John Robb, Wellcome's chairman and chief executive, has made no bones about his opposition to such a move. The relentless loss of top management from the group may hint at board-level disagreement.

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in